RE: ConserV Bioscience Collaborate on Development of Broad-spectrum Coronavirus Vaccine19 Jan 2021 13:11
Can I just get some clarification on this? It would appear that ConserV Bioscience, a company formed by Seek, own the IP for FLU-v and AGS-v. They are looking to develop the technology further along with Livermore Labs. In the past they have sub-licenced these products to Imutex, a company owned by Seek and OO. Does this mean that the current licence that Imutex hold will benefit from the development of the products, and that therefore the asset being licenced will be worth more if there are positive results? Can anyone clarify the situation?